Evidence map›Paper›PMID 25320276›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Regulatory T cells in central nervous system injury: a double-edged sword.

James T Walsh, Jingjing Zheng, Igor Smirnov, Ulrike Lorenz, Kenneth Tung, Jonathan Kipnis

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. The brain's regulators.Nature immunology · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Role of regulatory T cells in spinal cord injury.European journal of medical research · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James T WalshCenter for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA 22908; Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, VA 22908; Graduate Program in Neuroscience, University of Virginia, Charlottesville, VA 22908, Medical Scientist Training Program, School of Medicine, University of Virginia, Charlottesville, VA 22908;
Jingjing ZhengCenter for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA 22908; Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, VA 22908; Institute of Neurosciences, Fourth Military Medical University, Xi'an 710038, China;
Igor SmirnovCenter for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA 22908; Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, VA 22908;
Ulrike LorenzBeirne Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908; Department of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, VA 22908; and.
Kenneth TungDepartment of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, VA 22908; and Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908.
Jonathan KipnisCenter for Brain Immunology and Glia, School of Medicine, University of Virginia, Charlottesville, VA 22908; Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, VA 22908; Graduate Program in Neuroscience, University of Virginia, Charlottesville, VA 22908, Medical Scientist Training Program, School of Medicine, University of Virginia, Charlottesville, VA 22908; kipnis@virginia.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
Role of SHP-1 in T cell activation and developmentR01AI048672 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LORENZ, ULRIKE · 2001 to 2009
$3.3M
Regulatory T cells in central nervous system injuryR01NS061973 · NINDS · UNIVERSITY OF VIRGINIA · PI KIPNIS, JONATHAN · 2009 to 2013
$1.6M
NIGMS NIH HHS T32 GM007267NINDS NIH HHS NS061973NINDS NIH HHS R01 NS061973
6 · The paper itself

Abstract

Previous research investigating the roles of T effector (T(eff)) and T regulatory (T(reg)) cells after injury to the CNS has yielded contradictory conclusions, with both protective and destructive functions being ascribed to each of these T cell subpopulations. In this work, we study this dichotomy by examining how regulation of the immune system affects the response to CNS trauma. We show that, in response to CNS injury, T(eff) and T(reg) subsets in the CNS-draining deep cervical lymph nodes are activated, and surgical resection of these lymph nodes results in impaired neuronal survival. Depletion of T(reg), not surprisingly, induces a robust T(eff) response in the draining lymph nodes and is associated with impaired neuronal survival. Interestingly, however, injection of exogenous T(reg) cells, which limits the spontaneous beneficial immune response after CNS injury, also impairs neuronal survival. We found that no T(reg) accumulate at the site of CNS injury, and that changes in T(reg) numbers do not alter the amount of infiltration by other immune cells into the site of injury. The phenotype of macrophages at the site, however, is affected: both addition and removal of T(reg) negatively impact the numbers of macrophages with alternatively activated (tissue-building) phenotype. Our data demonstrate that neuronal survival after CNS injury is impaired when T(reg) cells are either removed or added. With this exacerbation of neurodegeneration seen with both addition and depletion of T(reg), we recommend exercising extreme caution when considering the therapeutic targeting of T(reg) cells after CNS injury, and possibly in chronic neurodegenerative conditions.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell SurvivalFemaleHumansImmunophenotypingLymph NodesLymphocyte ActivationMacrophagesMiceMice, Inbred C57BLNeuronsOptic Nerve InjuriesRetinaT-Lymphocytes, Regulatory

Identifiers

PMID25320276
PMCPMC4225170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.